DK3016665T3 - Konditioneret medium fra humane voksne leverstamceller og dets anvendelse i behandlingen af leverlidelser - Google Patents
Konditioneret medium fra humane voksne leverstamceller og dets anvendelse i behandlingen af leverlidelser Download PDFInfo
- Publication number
- DK3016665T3 DK3016665T3 DK14753019T DK14753019T DK3016665T3 DK 3016665 T3 DK3016665 T3 DK 3016665T3 DK 14753019 T DK14753019 T DK 14753019T DK 14753019 T DK14753019 T DK 14753019T DK 3016665 T3 DK3016665 T3 DK 3016665T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- stem cells
- conditioned medium
- human adult
- adult liver
- Prior art date
Links
- 239000003636 conditioned culture medium Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 210000004185 liver Anatomy 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/14—Coculture with; Conditioned medium produced by hepatocytes
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13175442 | 2013-07-05 | ||
PCT/EP2014/064437 WO2015001124A1 (en) | 2013-07-05 | 2014-07-07 | Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3016665T3 true DK3016665T3 (da) | 2019-11-25 |
Family
ID=48792979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14753019T DK3016665T3 (da) | 2013-07-05 | 2014-07-07 | Konditioneret medium fra humane voksne leverstamceller og dets anvendelse i behandlingen af leverlidelser |
Country Status (6)
Country | Link |
---|---|
US (3) | US20160129047A1 (da) |
EP (1) | EP3016665B1 (da) |
JP (1) | JP6474394B2 (da) |
DK (1) | DK3016665T3 (da) |
ES (1) | ES2759228T3 (da) |
WO (1) | WO2015001124A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2759228T3 (es) | 2013-07-05 | 2020-05-08 | Univ Catholique Louvain | Medio acondicionado de células madre de hígado de adultos y su uso en el tratamiento de trastornos del hígado |
JP2017530697A (ja) * | 2014-08-28 | 2017-10-19 | プロメセラ バイオサイエンシーズ エス.アー./エンヌ.フェー. | 成体肝前駆細胞を作製する方法 |
CL2015002971A1 (es) * | 2015-10-05 | 2016-06-24 | Univ Del Desarrollo | Composición biofarmacológica que comprende componentes producidos y/o secretados por células troncales mesenquimales (msc), que permite recuperar la capacidad regenerativa tisular, en una situación de esteatosis hepática, o donde la capacidad de regeneración endógena del tejido hepático se encuentra inhibida |
MA45274A (fr) * | 2016-03-02 | 2019-01-09 | Univ Catholique Louvain | Préparations améliorées de cellules progénitrices hépatiques adultes |
WO2017191234A1 (en) * | 2016-05-06 | 2017-11-09 | Unicyte Ev Ag | Pharmaceutical carriers containing mirnas for use in the treatment of fibrotic diseases caused by hyperglycemia |
SG11202110476YA (en) | 2019-03-26 | 2021-10-28 | Promethera Therapeutics Sa | Adult liver progenitor cells for treating acute-on-chronic liver failure |
KR20220081368A (ko) | 2019-10-09 | 2022-06-15 | 셀라온 에스에이 | 혈관 과투과성을 특징으로 하는 장애에서 간 전구세포 또는 줄기세포, 이의 용해물 및/또는 조건화 배지의 사용 |
EP3881853A1 (en) * | 2020-03-20 | 2021-09-22 | Promethera Therapeutics Sa | Human allogeneic liver-derived progenitor cells for use in the treatment of inflammatory and infectious lung diseases and systemic inflammation |
CN113621557A (zh) * | 2021-09-02 | 2021-11-09 | 中国烟草总公司郑州烟草研究院 | 一种人肝微粒体与细胞共培养体系及其构建方法和应用 |
CN114748505A (zh) * | 2022-01-17 | 2022-07-15 | 桂林医学院 | 骨髓间充质干细胞外泌体的应用 |
WO2023180122A1 (en) | 2022-03-24 | 2023-09-28 | Université Catholique de Louvain | Use of human allogenic liver-derived progenitor cells for treating and/or preventing cellular senescence |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2917998B2 (ja) | 1988-02-05 | 1999-07-12 | ホワイトヘッド・インスティチュート・フォー・バイオメディカル・リサーチ | 修飾された肝細胞およびその用途 |
US6069005A (en) | 1991-08-07 | 2000-05-30 | Albert Einstein College Of Medicine Of Yeshwa University | Hapatoblasts and method of isolating same |
WO1994008598A1 (en) | 1992-10-09 | 1994-04-28 | Advanced Tissue Sciences, Inc. | Liver reserve cells |
US6576434B1 (en) | 1998-03-03 | 2003-06-10 | Genaera Corporation | Methods for identification of agents which modulate chloride channel activity |
US8778899B2 (en) | 1999-06-01 | 2014-07-15 | Sarah Ferber | Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
US6774120B1 (en) | 1999-06-01 | 2004-08-10 | Sarah Ferber | Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
EP1252293B1 (en) | 2000-01-19 | 2012-10-03 | University Of North Carolina At Chapel Hill | Liver tissue source |
GB0014136D0 (en) | 2000-06-10 | 2000-08-02 | Astrazeneca Ab | Combination therapy |
DE60221987T2 (de) | 2001-06-22 | 2008-05-15 | Stemcells, Inc., Palo Alto | Le-zellen (liver engrafting cells), assays und verwendungen davon |
WO2003033697A1 (en) | 2001-10-18 | 2003-04-24 | Ixion Biotechnology, Inc. | Conversion of liver stem and progenitor cells to pancreatic functional cells |
DE10202982A1 (de) | 2002-01-26 | 2003-07-31 | Augustinus Bader | Verfahren und Vorrichtung zum Einbringen von lebenden Zellen in eine biologische Körperflüssigkeit |
EP1624898A1 (en) | 2003-05-12 | 2006-02-15 | Sarah Ferber | Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
US20050074876A1 (en) | 2003-10-03 | 2005-04-07 | Inserm | Bipotential liver cell lines from wild-type mammalian liver tissue |
WO2005035738A1 (en) | 2003-10-07 | 2005-04-21 | Biomaster Inc. | Cell differentiation of adipose-derived precursor cells |
US20060222640A1 (en) | 2005-03-29 | 2006-10-05 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for treatment of thrombosis |
JP2008544957A (ja) | 2005-05-10 | 2008-12-11 | ユナイテッド ステイツ オブ アメリカ デパートメント オブ ヴェテランズ アフェアーズ | 間充織幹細胞による腎疾患及び多臓器不全の治療法と間充織幹細胞馴化培地 |
WO2006126219A1 (en) * | 2005-05-26 | 2006-11-30 | Fresenius Medical Care Deutschland G.M.B.H. | Liver progenitor cells |
US20070128174A1 (en) | 2005-09-21 | 2007-06-07 | Kleinsek Donald A | Methods and compositions for organ and tissue functionality |
ES2672205T3 (es) | 2005-12-21 | 2018-06-13 | Université Catholique de Louvain | Células madre hepáticas aisladas |
DK2578081T3 (da) | 2006-10-11 | 2016-06-27 | Massachusetts Gen Hospital | Sammensætninger, fremgangsmåder og anordninger til behandling af leversygdom |
WO2008070868A1 (en) | 2006-12-07 | 2008-06-12 | American Symbolic, Llc | Stem cell secretions and related methods |
US8568771B2 (en) | 2007-10-29 | 2013-10-29 | Fresenius Medical Care Deutschland G.M.B.H. | Use of microvesicles (MVs) derived from stem cells for preparing a medicament for endo/epithellal regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods |
KR101640381B1 (ko) | 2008-02-22 | 2016-07-18 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 중간엽 줄기세포 입자 |
PT2296672E (pt) * | 2008-06-11 | 2016-01-22 | Fresenius Medical Care De Gmbh | Meio condicionado de células progenitoras de fígado |
FI20095409A0 (fi) | 2009-04-14 | 2009-04-14 | Helsingin Yliopisto | Soluviljelysupplementti |
SG10201403202XA (en) | 2009-07-23 | 2014-08-28 | Agency Science Tech & Res | Pre-natal mesenchymal stem cells |
EP2333047A1 (en) | 2009-12-09 | 2011-06-15 | Fresenius Medical Care Deutschland GmbH | Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease |
US8415149B2 (en) | 2010-05-06 | 2013-04-09 | Gwo Xi Stem Cell Applied Technology Co., Ltd. | Hepatic progenitor cells and uses thereof |
WO2013110354A1 (en) | 2012-01-25 | 2013-08-01 | Université Catholique de Louvain | Compositions and methods for cell transplantation |
US20130302291A1 (en) | 2011-01-25 | 2013-11-14 | Universite Catholique De Louvain | Compositions and methods for cell transplantation |
ES2759228T3 (es) | 2013-07-05 | 2020-05-08 | Univ Catholique Louvain | Medio acondicionado de células madre de hígado de adultos y su uso en el tratamiento de trastornos del hígado |
MA45274A (fr) | 2016-03-02 | 2019-01-09 | Univ Catholique Louvain | Préparations améliorées de cellules progénitrices hépatiques adultes |
-
2014
- 2014-07-07 ES ES14753019T patent/ES2759228T3/es active Active
- 2014-07-07 US US14/899,661 patent/US20160129047A1/en not_active Abandoned
- 2014-07-07 EP EP14753019.0A patent/EP3016665B1/en active Active
- 2014-07-07 JP JP2016522658A patent/JP6474394B2/ja active Active
- 2014-07-07 WO PCT/EP2014/064437 patent/WO2015001124A1/en active Application Filing
- 2014-07-07 DK DK14753019T patent/DK3016665T3/da active
-
2018
- 2018-03-29 US US15/940,897 patent/US10874699B2/en active Active
-
2020
- 2020-11-25 US US17/104,202 patent/US11793837B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20160129047A1 (en) | 2016-05-12 |
US10874699B2 (en) | 2020-12-29 |
US20210077537A1 (en) | 2021-03-18 |
JP6474394B2 (ja) | 2019-02-27 |
WO2015001124A1 (en) | 2015-01-08 |
EP3016665A1 (en) | 2016-05-11 |
US20180289747A1 (en) | 2018-10-11 |
JP2016523883A (ja) | 2016-08-12 |
US11793837B2 (en) | 2023-10-24 |
ES2759228T3 (es) | 2020-05-08 |
EP3016665B1 (en) | 2019-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3016665T3 (da) | Konditioneret medium fra humane voksne leverstamceller og dets anvendelse i behandlingen af leverlidelser | |
HK1216251A1 (zh) | 吡唑並吡咯烷衍生物及其治病作用 | |
HK1217439A1 (zh) | 與毒性醛相關的疾病和治療 | |
BR112015022854A2 (pt) | pró-farmacos de fumaratos e uso do mesmo no tratamento de várias doenças | |
HK1215868A1 (zh) | 雙特異性構建體及其用於治療多種疾病的用途 | |
DK2793929T3 (da) | Konditioneret medium opnået fra mesenkymale stamceller fra placenta og anvendelser deraf i den terapeutiske behandling af præeklampsi | |
DK2996465T4 (da) | Fiskeopdrætsanlæg og anvendelse deraf | |
DK2774616T3 (da) | Anvendelse af roseburia i behandling og forebyggelse af fedmerelaterede sygdomme | |
IL271352B (en) | A pharmaceutical preparation containing a derivative of glutarimide and its use in the treatment of eosinophilic diseases | |
DK3088353T3 (da) | Bilirubinpartikler og deres fremstilling til anvendelse i terapi | |
DK3089707T3 (da) | Vævtransplantater og fremgangsmåder til fremstilling og brug af samme | |
PL3004112T3 (pl) | Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby | |
DK2510085T3 (da) | Vokenstamcelle-afledt konditioneret medium og/eller voksenstamceller til anvendelse i den terapeutiske behandling af en tumorsygdom | |
LTPA2020511I1 (lt) | Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui | |
IL245738A0 (en) | Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases | |
DK3722291T3 (da) | Indolinonforbindelser og deres anvendelse i behandlingen af fibrotiske sygdomme | |
DK3049473T3 (da) | Dobbeltderivatiserede chitosannanopartikler og fremgangsmåder til fremstilling og anvendelse heraf til genoverførsel in vivo | |
EP2949651A4 (en) | SUBSTITUTED BENZOTHIAZOLES AND THEIR THERAPEUTIC APPLICATIONS FOR THE TREATMENT OF HUMAN DISEASES | |
DK3153511T3 (da) | 2-acylaminothiazolderivat til anvendelse i forebyggelsen eller behandlingen af blære- og urinvejssygdomme | |
DK3083678T3 (da) | Midler og fremgangsmåder til at modvirke myeloproliferative eller lymfoproliferative forstyrrelser | |
EP2943593A4 (en) | DIAGNOSIS AND TREATMENT OF VIRUS DISEASES | |
SG11201701618SA (en) | Use of tetrahydropyridines in the treatment of sodium channel related disease and disorders | |
EP2954778A4 (en) | ANIMAL MODEL FOR EVALUATING THE PERFORMANCE OF A HEMOSTATIC AGENT FOR INDUCING HEMORRHAGE AT THE COMMON CAROTID ARTERY OR SINUS SAGITTAL TOP, AND USE THEREOF | |
AP2015008849A0 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
DK3190950T3 (da) | Forbedringer i og i sammenhæng med oftalmoskoper |